Embryonic Death and Early Pregnancy Loss

Embryonic death and early pregnancy loss (EDEPL) in dogs and cats refers to the spontaneous demise of the conceptus during the embryonic period, which spans from fertilization to the completion of organogenesis, approximately days 0 to 35 of gestation in the bitch (with implantation occurring around days 18-21) and days 0 to 30 in the queen. This condition is a significant cause of reproductive failure, often manifesting as resorption, abortion, or a reduction in litter size. The embryonic period is characterized by rapid cellular differentiation, implantation, and placentation, making it highly vulnerable to genetic, hormonal, infectious, and environmental insults. Early pregnancy loss is distinct from fetal loss, which occurs after day 35 in the bitch and day 30 in the queen, when the fetal skeleton begins to mineralize and the conceptus is more resistant to certain insults. The clinical presentation can range from subclinical resorption, detected only by ultrasonography, to overt vaginal discharge and systemic illness. Understanding the complex interplay of maternal recognition of pregnancy, luteal function, and embryonic development is essential for accurate diagnosis and management.

The etiology of embryonic death and early pregnancy loss is multifactorial, encompassing infectious, hormonal, genetic, congenital, neoplastic, iatrogenic, and environmental causes. Infectious agents are prominent in both dogs and cats. In the bitch, Brucella canis is a primary bacterial cause, leading to placentitis and embryonic death, often with minimal clinical signs. Canine herpesvirus-1 (CHV-1) is a viral cause, particularly in naive bitches, causing necrotizing placentitis and fetal death, often with characteristic multifocal hemorrhagic lesions. Feline panleukopenia virus (feline parvovirus) can cause embryonic death in queens, as can feline herpesvirus-1 and feline leukemia virus. Toxoplasma gondii and Neospora caninum are protozoal agents that can cross the placenta and cause embryonic loss. Hormonal causes include luteal insufficiency, characterized by inadequate progesterone production (<2 ng/mL in the bitch) to maintain pregnancy, and hypoluteoidism, which may be primary or secondary to premature luteal regression. Genetic abnormalities, such as chromosomal aneuploidy or lethal mutations, are estimated to account for a significant proportion of early embryonic losses in all mammals. Congenital defects, including uterine malformations (e.g., unicornuate uterus, segmental aplasia), can impair implantation and embryonic survival. Iatrogenic causes include inappropriate administration of exogenous hormones, such as glucocorticoids or prostaglandins, and certain drugs (e.g., etoposide, retinoids) that are embryotoxic. Environmental stressors, including poor nutrition, obesity, extreme temperatures, and transportation, can disrupt endocrine balance and compromise embryonic viability. Additionally, maternal systemic diseases, such as hypothyroidism, diabetes mellitus, and renal insufficiency, can adversely affect the uterine environment and embryonic development.

Embryonic death and early pregnancy loss is a common reproductive disorder in dogs and cats, with reported incidence rates varying widely depending on the population and diagnostic methods. In dogs, the overall pregnancy loss rate (including embryonic and fetal) is estimated to be 10-20%, with early embryonic loss accounting for a substantial proportion. In cats, the incidence is similarly significant, with studies reporting resorption rates of 10-15% in queens. Breed predispositions are recognized in dogs; for example, Golden Retrievers, Labrador Retrievers, and German Shepherd Dogs may have a higher incidence of embryonic loss, possibly due to genetic factors or breed-specific endocrine profiles. Age is a critical factor, with older bitches (>6 years) and queens (>5 years) showing increased embryonic loss, likely due to oocyte senescence and reduced luteal function. Nulliparous females may have higher risk due to uterine immaturity or subclinical infections. Breeding management plays a role; bitches bred too early or too late relative to ovulation have lower conception rates and higher embryonic loss. In kennel environments, infectious outbreaks (e.g., CHV-1) can cause epidemic early pregnancy loss. In cats, multi-cat households and catteries are at higher risk for infectious causes. Genetic predispositions are evident in certain lines, with inbreeding increasing the risk of lethal alleles. Overall, the condition is a leading cause of infertility and reduced litter size, impacting breeding programs and pet populations.

The pathophysiology of embryonic death and early pregnancy loss involves disruption of the delicate maternal-fetal interface and endocrine support. After fertilization, the embryo travels through the oviduct and enters the uterus around day 9-10 in the bitch, with implantation occurring on days 18-21. The embryo relies on the uterine microenvironment, which is primed by progesterone from the corpora lutea. Progesterone is essential for endometrial glandular development, secretion of uterine milk (histotroph), and maintenance of a quiescent myometrium. Luteal insufficiency, with progesterone levels falling below 2 ng/mL in the bitch, leads to endometrial degeneration, inadequate histotroph, and embryonic death. Infectious agents cause damage through direct cytolysis or inflammation. Brucella canis invades the placenta and uterus, causing placentitis, necrosis, and abortion. CHV-1 replicates in the placenta and fetus, causing multifocal necrosis and hemorrhage, leading to embryonic death. Feline panleukopenia virus targets rapidly dividing cells, including embryonic tissues, causing widespread necrosis. Protozoal infections (Toxoplasma, Neospora) cause placental necrosis and fetal encephalitis. Genetic abnormalities, such as aneuploidy, lead to developmental arrest and resorption. Endocrine disruptors, including exogenous glucocorticoids, can antagonize progesterone action or induce premature luteolysis. Stress-induced cortisol release can suppress LH secretion, leading to luteal insufficiency. Uterine pathology, such as cystic endometrial hyperplasia (CEH), alters the endometrial environment, impairing implantation and placentation. In all cases, the final common pathway is disruption of the fetal-maternal unit, leading to embryonic death, resorption, or expulsion.

Predisposing factors for embryonic death and early pregnancy loss are numerous and can be intrinsic or extrinsic. Intrinsic factors include advanced maternal age, which is associated with oocyte and embryo quality decline, and reduced luteal function. Genetic predisposition, including chromosomal abnormalities in the embryo or parental carrier status for lethal mutations, increases risk. Uterine abnormalities, such as segmental aplasia, unicornuate uterus, or endometrial cysts, impair implantation. Endocrine disorders, including hypothyroidism, diabetes mellitus, and hyperadrenocorticism, can disrupt pregnancy maintenance. Obesity and poor body condition are associated with altered hormonal profiles and increased inflammatory cytokines, adversely affecting embryonic survival. Nulliparity may increase risk due to subclinical uterine infections or inadequate uterine priming. Extrinsic factors include improper breeding timing, leading to fertilization of aged oocytes or spermatozoa, which increases embryonic death. Poor kennel hygiene and overcrowding facilitate the spread of infectious agents like CHV-1 and Brucella canis. Stress from transportation, changes in environment, or intense training can elevate cortisol levels, suppressing progesterone. Nutritional deficiencies, particularly of protein, vitamins (A, E, B-complex), and minerals (zinc, selenium), compromise embryonic development. Iatrogenic factors, such as administration of prostaglandins, glucocorticoids, or certain antibiotics (e.g., tetracyclines) during pregnancy, can cause embryonic loss. Environmental toxins, including pesticides and mycotoxins (e.g., zearalenone), have estrogenic or anti-progestogenic effects. In cats, stress and poor nutrition are significant, especially in catteries.

Clinical signs of embryonic death and early pregnancy loss vary depending on the stage of gestation and the underlying cause. In many cases, especially with early embryonic death and resorption, there may be no external signs, and the condition is only detected by ultrasonography as a reduction in the number of gestational sacs or the presence of anechoic fluid with no embryo. When clinical signs are present, they may include a serous to mucoid vaginal discharge, which can be clear, brown, or hemorrhagic, often without systemic illness. In cases of infectious abortion, the discharge may be purulent or fetid, and the female may show signs of systemic illness, including fever, lethargy, anorexia, and depression. Abdominal palpation may reveal a reduction in uterine size or the presence of fluid-filled uterine horns, but this is often unreliable. In some cases, the female may show behavioral changes, such as nesting or restlessness, and may pass embryonic tissue or placental remnants. In cases of luteal insufficiency, there may be a history of previous pregnancy loss, and the female may have a normal estrous cycle but fail to maintain pregnancy. In queens, signs are similar, with vaginal discharge and systemic signs if infection is present. It is important to note that many bitches and queens with early embryonic loss do not exhibit any clinical signs, and the condition is often diagnosed retrospectively when a smaller-than-expected litter is delivered.

Differential diagnoses for embryonic death and early pregnancy loss include: 1) Fetal death and abortion (after day 35 in the bitch, day 30 in the queen), which can be distinguished by the presence of fetal skeletal mineralization on radiographs and more advanced development on ultrasound. 2) Open pyometra, which presents with purulent vaginal discharge, systemic signs, and uterine distension on ultrasound, but without pregnancy. 3) Vaginitis, which causes vaginal discharge but no uterine involvement, and can be ruled out by ultrasound and cytology. 4) Metritis, which occurs postpartum or post-mating, with systemic signs and uterine infection, but not necessarily associated with pregnancy. 5) Pseudopregnancy (pseudocyesis), which can cause mammary development and behavioral changes, but no pregnancy on ultrasound. 6) Uterine torsion or rupture, which presents with acute abdominal pain and shock, and is a surgical emergency. 7) Ectopic pregnancy, which is rare but can cause abdominal pain and mass effect. 8) Hydrometra or mucometra, which can cause uterine distension but no embryonic structures. 9) Ovarian remnant syndrome, which can cause estrous behavior and hormonal changes, but no pregnancy. 10) Infertility due to male factors, such as poor semen quality, which can result in failure to conceive, but not embryonic loss per se. Definitive diagnosis requires a combination of history, clinical signs, ultrasonography, and laboratory testing.

The diagnostic algorithm for embryonic death and early pregnancy loss begins with a thorough history, including breeding dates, previous reproductive history, and any potential exposures to infectious agents or toxins. Clinical examination should include assessment of vaginal discharge, abdominal palpation, and general health status. The next step is ultrasonography, which is the most valuable diagnostic tool. In early pregnancy (days 20-30), ultrasound can detect gestational sacs, embryos, and fetal heartbeats. Embryonic death is confirmed by the absence of a heartbeat in an embryo that was previously viable, or by the presence of a gestational sac with no embryo (empty sac). Serial ultrasound examinations (every 2-3 days) are recommended to monitor embryonic development and detect resorption. Serum progesterone measurement is crucial to assess luteal function; levels below 2 ng/mL in the bitch indicate luteal insufficiency. Other hormonal assays, such as estrogen and LH, may be useful to confirm ovulation timing. Vaginal cytology can help stage the estrous cycle and detect inflammation. Complete blood count and serum biochemistry can identify systemic infection or metabolic disorders. If infectious causes are suspected, serology for Brucella canis, CHV-1, Toxoplasma, and Neospora should be performed, along with bacterial culture and PCR of vaginal discharge or uterine contents. In cases of recurrent embryonic loss, karyotyping of the parents and histopathology of resorbed tissues may be indicated. The algorithm should be systematic, starting with non-invasive imaging and progressing to more invasive diagnostics as needed.

Laboratory findings in embryonic death and early pregnancy loss vary depending on the cause. Serum progesterone is a critical parameter; in the bitch, levels should be >2 ng/mL for pregnancy maintenance. Levels below this threshold indicate luteal insufficiency. In the queen, progesterone levels >1 ng/mL are generally sufficient. Estrogen levels may be elevated if there is ovarian pathology, but are not routinely measured. Hematology may reveal leukocytosis with a left shift in cases of bacterial infection, or lymphopenia in viral infections. Serum biochemistry may show azotemia and elevated liver enzymes in cases of systemic disease. In cases of hypothyroidism, total T4 and free T4 may be low, with elevated TSH. Vaginal cytology can show the presence of neutrophils and bacteria in infectious cases, or a shift from superficial to intermediate cells if progesterone is low. Bacterial culture of vaginal discharge or uterine contents can identify pathogens such as Brucella canis, E. coli, Streptococcus spp., and Mycoplasma spp. PCR testing for CHV-1, feline herpesvirus, and other infectious agents is highly sensitive. Histopathology of resorbed tissues or placenta may reveal characteristic lesions, such as necrosis, hemorrhage, or inflammation. In cases of genetic causes, karyotyping of the parents may reveal chromosomal abnormalities. Overall, laboratory findings should be interpreted in conjunction with imaging and clinical signs.

Imaging plays a pivotal role in the diagnosis and monitoring of embryonic death and early pregnancy loss. Abdominal ultrasonography is the gold standard. In the bitch, gestational sacs can be visualized as early as day 18-20, and embryos with heartbeats by day 23-25. Fetal heart rate (FHR) is a critical indicator of viability; normal FHR ranges from 180-240 beats per minute (bpm) in early pregnancy, and a FHR below 160 bpm is associated with fetal distress and impending death. In embryonic death, ultrasound may show a gestational sac with no embryo, a collapsed sac, or an embryo with no heartbeat. Serial ultrasound examinations (every 2-3 days) can detect resorption, which appears as a decrease in the number of gestational sacs or the presence of hyperechoic material within the sac. Uterine wall thickness and echogenicity may be altered in cases of infection or inflammation. In cases of luteal insufficiency, the uterine environment may appear normal, but embryonic development may be retarded. Radiography is not useful in early pregnancy, as fetal mineralization does not occur until day 42-45 in the bitch and day 35-40 in the queen. However, radiography can be used to confirm fetal death in later stages by the presence of overlapping fetal bones or gas within the uterus. CT and MRI are rarely used but may be helpful in evaluating uterine abnormalities or masses. Vaginoscopy can be used to assess vaginal discharge and collect samples for culture. Overall, ultrasonography is the most sensitive and specific imaging modality for early pregnancy loss.

Cytology and histopathology are valuable in diagnosing the underlying cause of embryonic death and early pregnancy loss. Vaginal cytology can help stage the estrous cycle and detect inflammation. In early pregnancy, the vaginal epithelium is typically non-cornified, with intermediate and parabasal cells. The presence of neutrophils and bacteria may indicate infection. Fine-needle aspiration of any uterine or ovarian masses can provide cytological evidence of neoplasia or inflammation. Histopathology of resorbed embryonic tissue, placenta, or uterine biopsies can reveal characteristic lesions. In cases of Brucella canis infection, the placenta may show necrotizing placentitis with infiltration of neutrophils and macrophages. CHV-1 infection causes multifocal necrosis and intranuclear inclusion bodies in trophoblasts. Feline panleukopenia virus causes necrosis of the intestinal crypts and bone marrow. Protozoal infections may show tachyzoites or cysts in tissues. In cases of luteal insufficiency, the endometrium may show inadequate glandular development and reduced secretory activity. Cystic endometrial hyperplasia (CEH) is characterized by cystic dilation of endometrial glands and fibrosis. In cases of genetic abnormalities, histopathology may show developmental arrest or abnormal embryonic structures. Special stains, such as immunohistochemistry for infectious agents, can enhance diagnostic accuracy. Overall, cytology and histopathology are essential for a definitive etiological diagnosis.

Treatment of embryonic death and early pregnancy loss depends on the underlying cause and the stage of gestation. In cases of luteal insufficiency, progesterone supplementation is the mainstay. In the bitch, natural progesterone (in oil) can be administered at a dose of 1-2 mg/kg IM every 48-72 hours, or micronized progesterone orally at 2-4 mg/kg q12h. Alternatively, synthetic progestins such as megestrol acetate (0.5 mg/kg PO q24h) or altrenogest (0.088 mg/kg PO q24h) may be used, but natural progesterone is preferred. Progesterone levels should be monitored to maintain >2 ng/mL. In cases of infectious causes, appropriate antimicrobial therapy is indicated. For Brucella canis, treatment is controversial and often unsuccessful; antibiotics such as minocycline (5-10 mg/kg PO q12h) combined with streptomycin (5 mg/kg IM q24h) for 2-3 weeks may be attempted, but euthanasia is often recommended due to zoonotic risk. For CHV-1, there is no specific antiviral therapy; supportive care and vaccination may be considered. For bacterial infections, broad-spectrum antibiotics such as amoxicillin-clavulanate (12.5-25 mg/kg PO q12h) or enrofloxacin (5 mg/kg PO q24h) can be used, but caution is needed with fluoroquinolones in young animals. In cases of systemic illness, supportive care with intravenous fluids, antiemetics, and nutritional support is essential. If embryonic death is confirmed and the uterus is not completely evacuated, medical management with prostaglandins (e.g., dinoprost tromethamine 0.1-0.25 mg/kg SC q8-12h) and/or cabergoline (5 mcg/kg PO q24h) may be used to induce uterine evacuation. In cases of severe uterine infection or when medical management fails, ovariohysterectomy may be indicated. Surgical intervention is also required for uterine torsion or rupture. In all cases, breeding management should be reviewed to optimize future conception.

The prognosis for embryonic death and early pregnancy loss depends on the underlying cause and the timeliness of intervention. In cases of luteal insufficiency, the prognosis is generally good if progesterone supplementation is initiated early and maintained adequately; many bitches can carry a litter to term with appropriate support. However, if the cause is infectious, the prognosis is guarded to poor, especially for Brucella canis, which is difficult to eliminate and has zoonotic implications. CHV-1 infection can cause high embryonic loss, but subsequent pregnancies may be normal if the bitch has developed immunity. Genetic causes carry a poor prognosis for the affected pregnancy, but future pregnancies may be successful if the genetic abnormality is not recurrent. In cases of systemic disease, the prognosis depends on the control of the underlying condition. Overall, the short-term prognosis for the current pregnancy is often poor if embryonic death has already occurred, as the conceptus is nonviable. The medium-term prognosis for future fertility is variable; many females can conceive again, but the risk of recurrence is high if the underlying cause is not addressed. Long-term prognosis is generally good for non-infectious causes, but infectious causes may lead to chronic infertility. Negative prognostic indicators include recurrent embryonic loss, advanced maternal age, and severe uterine pathology.

Follow-up care for embryonic death and early pregnancy loss is crucial to monitor recovery and plan future breeding. After diagnosis, serial ultrasonography should be performed every 2-3 days to confirm complete uterine evacuation and assess uterine involution. Serum progesterone levels should be monitored if luteal insufficiency was identified, to ensure adequate luteal function in future pregnancies. Vaginal cytology can be repeated to monitor for resolution of inflammation. If infectious causes were identified, repeat cultures or serology may be needed to confirm clearance. In cases of Brucella canis, repeat serology is essential, and the animal should be isolated. For future breeding, a thorough breeding management plan should be developed, including optimal timing of mating based on progesterone and LH assays, and possibly progesterone supplementation during early pregnancy. In cases of recurrent embryonic loss, a complete workup, including karyotyping and uterine biopsy, may be recommended. Post-treatment monitoring should include regular physical examinations and assessment of general health. If ovariohysterectomy was performed, routine postoperative care is required. Overall, follow-up should be tailored to the individual case, with the goal of optimizing future reproductive success.

Clinical pearls: 1) Ultrasonography is the most reliable method to diagnose embryonic death; always confirm with serial scans. 2) Fetal heart rate below 160 bpm in the bitch is a sign of fetal distress and impending death. 3) Progesterone levels below 2 ng/mL in the bitch during early pregnancy indicate luteal insufficiency and require supplementation. 4) In cases of recurrent embryonic loss, consider genetic testing and infectious disease screening. 5) Brucella canis is a zoonotic risk; handle all discharges with gloves and disinfect. Pitfalls: 1) Do not administer prostaglandins to a female with a live pregnancy, as it will cause abortion. 2) Avoid using glucocorticoids during pregnancy, as they can cause embryonic loss. 3) Do not rely solely on abdominal palpation to diagnose pregnancy loss; it is unreliable. 4) Do not use tetracyclines or fluoroquinolones in pregnant animals, as they can affect fetal bone and cartilage development. 5) Do not assume that a single low progesterone measurement is diagnostic; repeat and consider the stage of pregnancy. 6) In cats, be cautious with the use of enrofloxacin, as it can cause retinal toxicity. 7) Always rule out infectious causes before attributing embryonic loss to hormonal factors.

Current drug protocols for embryonic death and early pregnancy loss are based on Plumb's Veterinary Drug Handbook and theriogenology guidelines. For luteal insufficiency: Natural progesterone (in oil) 1-2 mg/kg IM every 48-72 hours, or micronized progesterone 2-4 mg/kg PO q12h. Monitor serum progesterone to maintain >2 ng/mL. For uterine evacuation after confirmed embryonic death: Dinoprost tromethamine (PGF2α) 0.1-0.25 mg/kg SC q8-12h, with or without cabergoline 5 mcg/kg PO q24h. For bacterial infections: Amoxicillin-clavulanate 12.5-25 mg/kg PO q12h; enrofloxacin 5 mg/kg PO q24h (use with caution in young animals); doxycycline 5-10 mg/kg PO q12h (avoid in pregnant animals). For Brucella canis: Minocycline 5-10 mg/kg PO q12h combined with streptomycin 5 mg/kg IM q24h for 2-3 weeks (controversial). For supportive care: Intravenous fluids (Lactated Ringer's solution) at maintenance rates (60-100 mL/kg/day), antiemetics (maropitant 1 mg/kg SC q24h), and nutritional support. For systemic inflammation: NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h) may be used, but avoid in pregnant animals. Always consult the latest drug formularies for updated dosages and contraindications.

Evidence-based literature on embryonic death and early pregnancy loss in dogs and cats is limited but growing. Key studies include: 1) A study by Johnston et al. (2001) in 'Canine and Feline Theriogenology' reported that embryonic loss occurs in 10-20% of canine pregnancies, with luteal insufficiency being a common cause. 2) A study by England and von Heimendahl (2010) in the 'BSAVA Manual of Small Animal Reproduction' emphasized the importance of ultrasonography in diagnosing early pregnancy loss and monitoring fetal viability. 3) A study by Verstegen et al. (2002) evaluated the use of aglepristone for pregnancy termination, which is relevant for managing unwanted pregnancies but not directly for embryonic loss. 4) A study by Root Kustritz (2010) in 'Clinical Canine and Feline Reproduction' reviewed the diagnosis and treatment of luteal insufficiency, recommending progesterone supplementation. 5) A study by Lopate (2012) in 'Theriogenology' highlighted the role of infectious agents, particularly Brucella canis and CHV-1, in early pregnancy loss. 6) A study by Zambelli et al. (2013) in 'Journal of Feline Medicine and Surgery' reported on the incidence of embryonic resorption in queens. 7) A meta-analysis by Fontaine et al. (2018) in 'Reproduction in Domestic Animals' summarized the efficacy of progesterone supplementation in preventing pregnancy loss in bitches. Consensus guidelines from the American College of Theriogenologists (ACT) and the European Society for Small Animal Reproduction (EVSSAR) recommend a systematic approach to diagnosis, including ultrasonography and progesterone measurement, and emphasize the importance of identifying infectious causes to prevent zoonotic transmission.